Imaging and cancer: Research strategy of the American College of Radiology Imaging Network

被引:36
作者
Aberle, DR
Chiles, C
Gatsonis, C
Hillman, BJ
Johnson, CD
McClennan, BL
Mitchell, DG
Pisano, ED
Schnall, MD
Sorensen, AG
机构
[1] Univ Virginia Hlth Syst, Charlottesville, VA 22908 USA
[2] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA USA
[3] Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27109 USA
[4] Brown Univ, Sanders Brown Stat Sci, Dept Radiol, Providence, RI 02912 USA
[5] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Radiol, Rochester, MN 55905 USA
[6] Yale Univ, Sch Med, Dept Radiol, New Haven, CT USA
[7] Thomas Jefferson Univ, Sch Med, Dept Radiol, Philadelphia, PA 19107 USA
[8] Univ N Carolina, Sch Med, Dept Radiol, Chapel Hill, NC 27514 USA
[9] Univ Penn, Sch Med, Dept Radiol, Philadelphia, PA 19104 USA
[10] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA
关键词
D O I
10.1148/radiol.2353041760
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The American College of Radiology Imaging Network (ACRIN) is a cooperative group funded by the National Cancer Institute and dedicated to developing and conducting clinical trials of diagnostic imaging and image-guided treatment technologies. ACRIN's six disease site committees are responsible for developing scientific strategies and resultant trials within the framework of ACRIN's five key hypotheses: (a) Screening and early detection with imaging can reduce cancer-specific mortality. (b) Less invasive image-guided therapeutic methods can reduce the mortality and morbidity associated with treating cancer. (c).Molecular-based phys- iologic and functional imaging can improve the diagnosis and staging of cancer, thus improving treatment. (d) Functional imaging can portray the effectiveness of, treatment earlier and more accurately, thus reducing mortality and improving the likelihood of a cure. (e) Informatics and other "smart systems" can improve the evaluation of patients with cancer,thus leading to better and more effective treat- ments. This article details ACRIN's research strategy according to disease site through the year 2007.((c)) RSNA, 2005.
引用
收藏
页码:741 / 751
页数:11
相关论文
共 70 条
[1]  
*AM CANC SOC, 2003, BREAST CANC FACTS FI
[2]   Stage IVB endometrial carcinoma: The role of cytoreductive surgery and determinants of survival [J].
Bristow, RE ;
Zerbe, MJ ;
Rosenshein, NB ;
Grumbine, FC ;
Montz, FJ .
GYNECOLOGIC ONCOLOGY, 2000, 78 (02) :85-91
[3]  
Bristow RE, 1996, CANCER, V78, P2049, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2049::AID-CNCR4>3.0.CO
[4]  
2-J
[5]   Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT [J].
Bristow, RE ;
del Carmen, MG ;
Pannu, HK ;
Cohade, C ;
Zahurak, ML ;
Fishman, EK ;
Wahl, RL ;
Montz, FJ .
GYNECOLOGIC ONCOLOGY, 2003, 90 (03) :519-528
[6]  
Brücher BLDM, 2001, ANN SURG, V233, P300
[7]  
Buck AK, 2003, J NUCL MED, V44, P1426
[8]   Focal therapy for prostate cancer 1996: Maximizing outcome [J].
Carroll, PR ;
Presti, JC ;
Small, E ;
Roach, M .
UROLOGY, 1997, 49 (3A) :84-94
[9]   Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors - Comparison with conventional MRI [J].
Chang, SC ;
Lai, PH ;
Chen, WL ;
Weng, HH ;
Ho, JT ;
Wang, JS ;
Chang, CY ;
Pan, HB ;
Yang, CF .
CLINICAL IMAGING, 2002, 26 (04) :227-236
[10]   A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines [J].
Chiarotto, JA ;
Hill, RP .
BRITISH JOURNAL OF CANCER, 1999, 80 (10) :1518-1524